Badger
发表于 2025-3-30 10:48:02
http://reply.papertrans.cn/23/2224/222312/222312_51.png
forager
发表于 2025-3-30 15:05:49
Diagnostic Pathways of Postmenopausal Bleedingndometrial sampling with or without hysteroscopy is recommended. Hysteroscopy is offered to women with ET of ≥10 mm, focal lesion on TVS, recurrent PMB irrespective of the ET, or inadequate endometrial biopsy.
充气球
发表于 2025-3-30 17:02:12
http://reply.papertrans.cn/23/2224/222312/222312_53.png
讨好女人
发表于 2025-3-30 22:02:04
http://reply.papertrans.cn/23/2224/222312/222312_54.png
同步左右
发表于 2025-3-31 01:14:53
Management of Adnexal Massese an adnexal mass into possibly benign or malignant. The IOTA simple rules and ORADS are two classification systems for adnexal masses on imaging. Tumor markers play an important role to determine the presence and type of malignant ovarian mass. Various triaging models like Risk of malignancy index,
使满足
发表于 2025-3-31 08:29:21
http://reply.papertrans.cn/23/2224/222312/222312_56.png
考得
发表于 2025-3-31 09:20:33
http://reply.papertrans.cn/23/2224/222312/222312_57.png
senile-dementia
发表于 2025-3-31 13:46:43
Platinum Resistant Ovarian Cancerlth related quality of life and use of maintenance therapy with bevacizumab and PARP inhibitors. Treatment of early recurrence (<6 months of completion of primary chemotherapy) usually consists of single agent non platinum drugs like liposomal doxorubicin, paclitaxel, etoposide and the overall respo
Kernel
发表于 2025-3-31 19:40:09
Metastatic Ovarian Canceristochemistry especially using CK7 and CK20 are the most commonly used antigens in differentiating between primary and metastatic ovarian tumours. Genetic testing is crucial for counselling and tailoring management. Treatment is mainly palliative chemotherapy while in select cases metastatectomy or
Commemorate
发表于 2025-4-1 00:42:39
http://reply.papertrans.cn/23/2224/222312/222312_60.png